Zhang, Y., Zhang, L., Zhang, X., Yao, X., Wang, T., Zhu, D., . . . Li, J. (2022). Phase 1 study of C-CAR088, a novel humanized anti-BCMA CAR T-cell therapy in relapsed/refractory multiple myeloma. BMJ Publishing Group.
Chicago Style (17th ed.) CitationZhang, Yan, et al. Phase 1 Study of C-CAR088, a Novel Humanized Anti-BCMA CAR T-cell Therapy in Relapsed/refractory Multiple Myeloma. BMJ Publishing Group, 2022.
MLA (9th ed.) CitationZhang, Yan, et al. Phase 1 Study of C-CAR088, a Novel Humanized Anti-BCMA CAR T-cell Therapy in Relapsed/refractory Multiple Myeloma. BMJ Publishing Group, 2022.
Warning: These citations may not always be 100% accurate.